Patients with moderate-to-severe psoriasis are not achieving clear or almost clear skin
Despite therapeutic advancements, a global patient survey of 8,338 participants completing validated instruments showed that approximately 57% of surveyed patients who are being treated for moderate-to-severe psoriasis have not achieved self-assessed clear/almost clear skin. Of those failing to meet their goals of treatment, the majority (56%) did not think it was possible to achieve the desired level of skin clearance.1
Level of skin clearance correlates with improvements in quality of life
Patients with poorly controlled psoriasis often experience discrimination and/or humiliation
due to their condition, including negative social interactions and lifestyle disruptions.1
94% of patients with moderate-to-severe psoriasis felt that their psoriasis imparted a moderate, large, or very large effect on quality of life as demonstrated by a cross-sectional, online, quantitative survey targeting adult patients in the USA (N=500).2
Many live in fear of the next flare-up. Given the impact of psoriasis on patients’ quality of life, the level of skin clearance is an outcome of interest for patients.1
More clarity on psoriasis
pathogenesis is needed
to help patients
Better understanding the inflammatory mechanism in psoriasis has led to targeted biologic treatments that inhibit key cytokines, including IL-17A, IL-12/IL-23, and TNFα.3 Despite these advances, a multinational, prospective, observational study involving 846 patients indicated that patient needs were still not being met.4 More clarity is still needed on the pathogenesis of psoriasis.
Only one in four patients treated with biologics have reported self-assessed complete skin clearance after six months of treatment.4
Mechanism of disease
Alleviating the burden of psoriasis begins with understanding the science.
